Vishwas Paralkar

4.0k total citations
50 papers, 3.0k citations indexed

About

Vishwas Paralkar is a scholar working on Molecular Biology, Rheumatology and Oncology. According to data from OpenAlex, Vishwas Paralkar has authored 50 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Rheumatology and 12 papers in Oncology. Recurrent topics in Vishwas Paralkar's work include TGF-β signaling in diseases (12 papers), Inflammatory mediators and NSAID effects (9 papers) and Bone health and treatments (8 papers). Vishwas Paralkar is often cited by papers focused on TGF-β signaling in diseases (12 papers), Inflammatory mediators and NSAID effects (9 papers) and Bone health and treatments (8 papers). Vishwas Paralkar collaborates with scholars based in United States, Croatia and Canada. Vishwas Paralkar's co-authors include A. Hari Reddi, Slobodan Vukičević, David D. Thompson, W A Grasser, N. S. Cunningham, Hua Zhu Ke, Hong Qi, Thomas A. Owen, Thomas A. Brown and Hynda K. Kleinman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Vishwas Paralkar

49 papers receiving 3.0k citations

Peers

Vishwas Paralkar
Yuji Amagai Japan
Shunsuke Uehara Japan
Vittorio Rosti Italy
Baruch Frenkel United States
Edith Bonnelye France
Noriyuki Namba Japan
W A Grasser United States
Edward C. Hsiao United States
Heather E. Ryan United States
Jean H.M. Feyen United States
Yuji Amagai Japan
Vishwas Paralkar
Citations per year, relative to Vishwas Paralkar Vishwas Paralkar (= 1×) peers Yuji Amagai

Countries citing papers authored by Vishwas Paralkar

Since Specialization
Citations

This map shows the geographic impact of Vishwas Paralkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vishwas Paralkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vishwas Paralkar more than expected).

Fields of papers citing papers by Vishwas Paralkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vishwas Paralkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vishwas Paralkar. The network helps show where Vishwas Paralkar may publish in the future.

Co-authorship network of co-authors of Vishwas Paralkar

This figure shows the co-authorship network connecting the top 25 collaborators of Vishwas Paralkar. A scholar is included among the top collaborators of Vishwas Paralkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vishwas Paralkar. Vishwas Paralkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jo, Ukhyun, Yasuhisa Murai, Keli Agama, et al.. (2022). TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor. Molecular Cancer Therapeutics. 21(7). 1090–1102. 30 indexed citations
2.
Aiello, Robert J., Kelli Jones, Lori Lopresti‐Morrow, et al.. (2020). Abstract 6249: CBX-12: A low pH targeting alphalex™-exatecan conjugate for the treatment of solid tumors. Cancer Research. 80(16_Supplement). 6249–6249. 2 indexed citations
3.
Goldberg, Daniel R., Stéphane De Lombaert, Robert J. Aiello, et al.. (2016). Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(3). 413–419. 29 indexed citations
4.
Erjavec, Igor, Tatjana Bordukalo-Nikšić, Jelena Brkljačić, et al.. (2016). Constitutively Elevated Blood Serotonin Is Associated with Bone Loss and Type 2 Diabetes in Rats. PLoS ONE. 11(2). e0150102–e0150102. 29 indexed citations
5.
Grgurević, Lovorka, Boris Maček, David R. Healy, et al.. (2011). Circulating Bone Morphogenetic Protein 1–3 Isoform Increases Renal Fibrosis. Journal of the American Society of Nephrology. 22(4). 681–692. 48 indexed citations
6.
Betts, Alison, Tracey Clark, Jianxin Yang, et al.. (2010). The Application of Target Information and Preclinical Pharmacokinetic/Pharmacodynamic Modeling in Predicting Clinical Doses of a Dickkopf-1 Antibody for Osteoporosis. Journal of Pharmacology and Experimental Therapeutics. 333(1). 2–13. 77 indexed citations
7.
Cameron, Kimberly O., Bruce A. Lefker, Hua Zhu Ke, et al.. (2009). Discovery of CP-533536: An EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation. Bioorganic & Medicinal Chemistry Letters. 19(7). 2075–2078. 24 indexed citations
8.
Terry, Ketti K., Wesley Lebel, Keith Riccardi, et al.. (2007). Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterus. Prostaglandins Leukotrienes and Essential Fatty Acids. 78(1). 3–10. 11 indexed citations
9.
Cameron, Kimberly O., Bruce A. Lefker, Margaret Y. Chu‐Moyer, et al.. (2006). Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in ovariectomized rats. Bioorganic & Medicinal Chemistry Letters. 16(7). 1799–1802. 19 indexed citations
10.
Ke, Hua Zhu, David T. Crawford, Hong Qi, et al.. (2006). A Nonprostanoid EP4 Receptor Selective Prostaglandin E2 Agonist Restores Bone Mass and Strength in Aged, Ovariectomized Rats. Journal of Bone and Mineral Research. 21(4). 565–575. 51 indexed citations
11.
Vukičević, Slobodan, Fran Borovečki, Lovorka Grgurević, et al.. (2006). Role of EP2 and EP4 receptor-selective agonists of prostaglandin E2 in acute and chronic kidney failure. Kidney International. 70(6). 1099–1106. 49 indexed citations
12.
Karan, Dev, Sonny L. Johansson, Ajay P. Singh, et al.. (2003). Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochemical and Biophysical Research Communications. 305(3). 598–604. 60 indexed citations
13.
Ke, Hua Zhu, Hong Qi, Qing Zhang, et al.. (2003). Deletion of the P2X7Nucleotide Receptor Reveals Its Regulatory Roles in Bone Formation and Resorption. Molecular Endocrinology. 17(7). 1356–1367. 229 indexed citations
14.
Paralkar, Vishwas, W A Grasser, Amy Baumann, et al.. (2002). Regulation of BMP‐7 expression by retinoic acid and prostaglandin E2. Journal of Cellular Physiology. 190(2). 207–217. 51 indexed citations
15.
Martin, Jennifer M., Xianwang Meng, Robert J. Lechleider, et al.. (2002). A novel link between the proteasome pathway and the signal transduction pathway of the Bone Morphogenetic Proteins (BMPs). BMC Cell Biology. 3(1). 15–15. 57 indexed citations
16.
Grasser, W A, Lydia C. Pan, David D. Thompson, & Vishwas Paralkar. (1997). Common mechanism for the estrogen agonist and antagonist activities of droloxifene. Journal of Cellular Biochemistry. 65(2). 159–171. 11 indexed citations
17.
Paralkar, Vishwas & Graeme Wistow. (1994). Cloning the Human Gene for Macrophage Migration Inhibitory Factor (MIF). Genomics. 19(1). 48–51. 86 indexed citations
18.
Vukičević, Slobodan, Vishwas Paralkar, Noreen S. Cunningham, J. Silvio Gutkind, & A. Hari Reddi. (1990). Autoradiographic localization of osteogenin binding sites in cartilage and bone during rat embryonic development. Developmental Biology. 140(1). 209–214. 29 indexed citations
19.
Reddi, A. H., N. Muthukumaran, Shaoying Ma, et al.. (1989). Initiation of Bone Development by Osteogenin and Promotion by Growth Factors. Connective Tissue Research. 20(1-4). 303–312. 32 indexed citations
20.
Paralkar, Vishwas, Arvind K.N. Nandedkar, & A. Hari Reddi. (1989). Affinity of osteogenin, an extracellular bone matrix associated protein initiating bone differentiation, for concanavalin A. Biochemical and Biophysical Research Communications. 160(2). 419–424. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuji Amagai Breakdown of academic impact, for papers by Shunsuke Uehara Breakdown of academic impact, for papers by Vittorio Rosti Breakdown of academic impact, for papers by Baruch Frenkel Breakdown of academic impact, for papers by Edith Bonnelye Breakdown of academic impact, for papers by Noriyuki Namba Breakdown of academic impact, for papers by W A Grasser Breakdown of academic impact, for papers by Edward C. Hsiao Breakdown of academic impact, for papers by Heather E. Ryan Breakdown of academic impact, for papers by Jean H.M. Feyen
Rankless by CCL
2026